Employees, research and development and environment
At the end of the financial year AddLife had 2,219 employees, compared with 1,802 at the beginning of the financial year. Completed acquisitions increased the number of employees by 355 (701). The average number of employees in 2022 was 2,157 (1,548).
Research and development
To a limited extent, the Group conducts its own research and development, primarily within Biolin in the Labtech business area. In the Medtech business area, development work is conducted on a digital platform in welfare technology. The digital platform contains solutions for connecting sensors and social alarms in the home, Camanio Care, as well as digital self-monitoring of specific health conditions, Camanio Health. The offering in welfare technology also includes products for housing adaptation as well as mobility aids and sensors.
None of the Group's Swedish subsidiaries conducts operations that require permits or are notifiable in accordance with the Environmental Code. None of the foreign subsidiaries operates with a corresponding permit or notification obligation. None of the Group's companies is involved in any environmental dispute.